Retrouvez les actionnaires et les dirigeants de la société AMPLITUDE SURG. This reasoned opinion will be prepared on the basis of the report drawn up by the independent expert and the opinion of staff representative bodies and will be replicated in the draft note in response prepared by the Company. Amplitude Surgical Dimitri Borchtch CFO finances@amplitude-surgical.com +33 (0)4 75 41 87 41 NewCap Investor Relations Mathilde Bohin/Thomas Grojean amplitude@newcap.eu +33 (0)1 44 … The Group would continue to be led by the current management team. Amplitude Surgical, which was founded in 1997, is a leading French player on the global surgical technology market for lower-limb orthopedics. approximately €115 million; and. Retrouvez tout l'historique action AMPLITUDE SURGICAL à la Bourse de Paris, la cotation jour par jour, les variations, le volume d'actions échangé et bien plus encore ! © PAI 2021. Read More. Amplitude Surgical NewCap NewCap Dimitri Borchtch Investor Relations Media Relations CFO Mathilde Bohin/Thomas Grojean Nicolas Merigeau finances@amplitude-surgical.com amplitude@newcap.eu Average annual growth rate over the 2008-2018 period, Number of countries covered via a network of sales representatives and exclusive distributors. Amplitude Surgical Dimitri Borchtch CFO finances@amplitude-surgical.com +33 (0)4 75 41 87 41 NewCap Investor Relations Mathilde Bohin/Thomas Grojean amplitude@newcap.eu +33 (0)1 44 … SEC Filings. The funds managed by Apax Partners would dispose their entire stake in the company in cash for €2.15 per share, i.e. Suivez en direct la cotation de l'action AMPLITUDE SURGICAL à la Bourse de Paris, découvrez les analyses, les recommandations et toute l'actualité de AMPLITUDE SURGICAL sur Investir - … : Registered in Luxembourg No. The implementation of the public tender offer is subject to the AMF clearance decision, and its completion could take place during the fourth quarter of 2020. a recovery of the activity due to the sanitary crisis and a return to the average annual growth trajectory of 5%, as presented in the universal registration document filed on November 19, 2019, resulting in 2020-21 (ending June 30, 2021) sales of around 10% above sales recorded in 2018-19 (ending June 30, 2019), i.e. In addition, the group offers orthopedic instruments, technical support and logistics services. Should the transaction be completed, the SPV controlled by PAI Partners will have to file a simplified public tender offer for all outstanding shares and all free shares which would potentially be issued at a price per share of €2.15. Investor Relations. 443 837 331. A leading player in France, Amplitude Surgical is developing abroad through its subsidiaries and a network of exclusive distributors and agents distributing its products in more than 30 countries. +33 (0)4 75 41 87 41. Provided the evolution of the COVID-19 pandemic can be contained without any further measures restricting economic activity, and assuming there is a catch-up effect on top of a return of activities to normal, the Company expects: Olivier Jallabert, founder, Chairman and CEO of Amplitude Surgical, said: “The Amplitude Surgical teams and I are pleased to join forces with PAI Partners, whose values and ambition we share. “We are pleased to have backed the company during a key phase of its development. PAI Partners would acquire, for a price of €2.15 per share and via a special purpose vehicle (the SPV), all the shares directly or indirectly held by Apax Partners and certain managers of the Company, through disposals in cash at a price of €2.15 per share and through contributions of shares based on the same valuation of the Company: The SPV would thus acquire approximately 52.3% of the Company’s share capital1 and voting rights. Amplitude surgical: Au bout de 10 ans de litige avec l'Urssaf, … 23/11/18 Amplitude surgical : Le CA trimestriel en hausse de +10,1% It is specified that neither Olivier Jallabert nor the two representatives of Apax Partners on the Company’s Board of Directors took part in discussions or voted at this Board Meeting. The Company will keep the market informed of the appointment process of the independent expert as well as the details of his mission. I would like to thank Apax Partners for their support over the last decade, including the last few months during which the Group has had to cope with an unprecedented global health crisis. Amplitude Surgical - 2017-18 annual results: sales of over €100 million, up +8% like-for-like, and solid EBITDA growth of +17% ... | February 8, 2021 Amplitude Surgical Philippe Garcia, +33 (0)4 75 41 87 41 CFO finances@amplitude-surgical.com or NewCap Investor Relations Marc Willaume, +33 (0)1 44 71 00 13 amplitude@newcap.eu or NewCap Media Relations Nicolas Merigeau, +33 (0)1 44 71 98 55 amplitude@newcap.eu Investors are advised to carefully read this International Offering Memorandum in its entirety, including the Annexes hereto. The proposed transaction which could be completed in the second half of 2020, remains subject to regulatory approvals in France and abroad. Amplitude Surgical Dimitri Borchtch CFO finances@amplitude-surgical.com +33 (0)4 75 41 87 41 NewCap Investor Relations Théodora Xu amplitude@newcap.eu +33 (0)1 44 71 20 42 The price of €2.15 per share represents a premium of: The Company’s Board of Directors, which met today, has favorably welcomed the potential acquisition of a majority stake by PAI Partners, and has decided to cooperate in order to allow the tender offer to be filed by the SPV controlled by PAI Partners as swiftly as possible. NewCap Investor Relations Mathilde Bohin/Thomas Grojean amplitude@newcap.eu +33 (0)1 44 71 94 94. With more than 45 years of experience, Apax Partners provides long-term equity funding to build and strengthen world-class companies. This release contains forward-looking statements that are based on assessments or assumptions that were reasonable at the date of the release, and which may change or be altered due, in particular, to random events or uncertainties and risks relating to the economic, financial , regulatory and competitive environment, the risks set out in the 2018/2019 Universal Registration Document, and any risks that are unknown or non-material to date that may subsequently occur. Valence (France), July 30, 2020, 11:30 pm CEST – PAI Partners has entered into exclusive negotiations with a view to acquiring a majority stake in Amplitude Surgical (ISIN: FR0012789667, Ticker: AMPLI, PEA-PME eligible) (the “Company”), a French leader on the global surgical technology market for lower-limb orthopedics. See the latest releases from Amplitude Healthcare Acquisition Corporation. Fondée en 1997 à Valence, AMPLITUDE est une actrice française de premier plan sur le marché mondial des technologies chirurgicales destinées à l’orthopédie pour les membres inférieurs. Offer price range: € 18.26 to € 24.34 per share an EBITDA margin of between 23 and 24% in 2020-21 (ending June 30, 2021), thus delaying by a year the target EBITDA margin presented in the universal registration document filed on November 19, 2019. amplitude@newcap.eu +33 (0)4 75 41 87 41, NewCap During these nine years, Amplitude Surgical, led by its founder Olivier Jallabert and his management team, has become one of the leading European orthopaedic companies. SIGNING OF THE CONTRACT RELATIVE TO THE ACQUISITION OF A MAJORITY STAKE IN AMPLITUDE SURGICAL BY PAI PARTNERS Valence (France), September 18, 2020, 07:00 pm CEST - Further to the press release of July 30, 2020 announcing that Apax Partners and the Management of Amplitude Surgical (ISIN: FR0012789667, Ticker: AMPLI, PEA-PME eligible) (the "Company") had … AMPLITUDE développe et commercialise des produits haut de gamme destinés à la chirurgie orthopédique couvrant les principales pathologies affectant la hanche, le genou et les extrémités, notamment pour les chirurgies du pied et de la cheville. Amplitude Surgical Dimitri Borchtch, CFO finances@amplitude-surgical.com +33 (0)4 75 41 87 41. Learn about our approach to corporate governance . Media Relations The transaction therefore remains subject to the conclusion of the final documentation and the customary regulatory approvals, notably regarding antitrust. 19,799,596 shares representing approximately 41.4% of the share capital, Olivier Jallabert, the Company’s founder, Chairman and CEO, and certain other senior executives (“. See the latest filings from Amplitude Healthcare Acquisition Corporation. Daniel Caille, independent Board Member, will be in charge of the review of the tender process and the steps enabling a reasoned opinion to be issued at the appropriate time. Founded in 1997 in Valence, France, Amplitude Surgical is a leading French player on the global surgical technology market for lower-limb orthopedics. Amplitude Surgical Dimitri Borchtch CFO finances@amplitude-surgical.com +33 (0)4 75 41 87 41 NewCap Investor Relations Mathilde Bohin/Thomas Grojean amplitude@newcap.eu +33 (0)1 44 … NewCap Media Relations Nicolas Merigeau … These funds invest in fast-growing small and mid-sized companies across four sectors of specialisation: Tech & Telecom, Consumer, Healthcare and Services. Our goal is to tap into new markets while bringing to market innovative new devices and equipment benefiting practitioners and their patients. Founded in 1997 in Valence, France, AMPLITUDE is a leading French player on the global surgical technology market for lower-limb orthopaedics. AMPLI Euronext Paris, sa capitalisation boursière et ses principales activités sur Boursorama We have demonstrated our resilience through this crisis thanks to our model, our proximity to our clients and the quality of our teams. Amplitude Surgical specializes in the design, manufacture and marketing of implants dedicated to surgery of knee and hip for hospitals. Profil du Groupe; Assemblées générales; Autres informations réglementées; Rapports financiers; Introduction en bourse; L'action Amplitude; Les médias; Contact B136689. The transfer of our controlling interest to a recognized player in healthcare investment will provide liquidity for all shareholders and enable the company to pursue its rapid expansion.”. +33 (0)1 44 71 94 94, NewCap Amplitude Surgical Philippe Garcia Chief Financial Officer philippe.garcia@amplitude-ortho.com +33 (0)4 75 41 87 41 or NewCap Investor Relations Marc Willaume amplitude@newcap.fr +33 … Investor Relations Today, our products are used in over 400 healthcare facilities in France, and we have sold over 180,000 implants and prostheses worldwide in the past three years, including more than 70,000 in FY 2018 alone. PAI Partners is characterised by its industrial approach to ownership combined with its sector-based organisation. Stefano Drago, Partner at PAI Partners, added: amplitude@newcap.eu. Press Releases. Amplitude Surgical and PAI Partners will keep the market informed of any significant change in the planned operation. Le cours de l'action AMPLITUDE SURG. Stock Information. Amplitude Surgical Announces That Apax Partners and the Company’s Management Have Entered Into Exclusive Negotiations With PAI Partners in Relation to … In close collaboration with surgeons, AMPLITUDE develops, numerous high value-added innovations to best meet the needs of patients, surgeons and healthcare facilities. Contacts: NewCap Investor Relations Florent Alba amplitude@newcap.fr +33 (0)1 44 71 98 55 NewCap Media Relations It manages €13.9 billion of dedicated buyout funds and, since 1994, has completed 75 transactions in 11 countries, representing over €50 billion in transaction value. The SPV intends to implement a mandatory squeeze-out following the public offer should the Company’s minority shareholders who do not tender their shares to the offer represent less than 10% of Amplitude Surgical’s shares and voting rights. PAI and PAI Partners are registered trademarks. AMPLITUDE develops and markets high-end products for orthopaedic surgery, covering the main disorders affecting the hip, knee and extremities, particularly foot and ankle surgery. The signing of the definitive agreements will only be able to take place once the consultation with the Company’s staff representative bodies has been completed. The Company’s 2019-20 fiscal year was significantly impacted by the COVID-19 pandemic. Consultez le profil complet sur LinkedIn et découvrez les relations de Marc, ainsi que des emplois dans des entreprises similaires. Amplitude Surgical Marc a 10 postes sur son profil. Amplitude Surgical en bref; Communiqués; Documentation. It is a great opportunity for us to invest in such a prestigious group and with such a talented management team.”, Bertrand Pivin, Partner at Apax Partners, said: It has also decided to initiate an information and consultation procedure with the Company’s staff representative bodies. PAI Partners is a leading European private equity firm with offices in Paris, London, Luxembourg, Madrid, Milan, Munich, New York and Stockholm. AMPLITUDE … finances@amplitude-surgical.com Voir le profil de Marc Bernard sur LinkedIn, le plus grand réseau professionnel mondial. +32.7% on the closing price of July 30, 2020; +32.0% on the volume-weighted average share price over the last 20 trading days; +53.5% on the volume-weighted average share price over the last 60 trading days; and. Investor Relations Mathilde Bohin/Thomas Grojean amplitude@newcap.eu +33 (0)1 44 71 94 94 NewCap Media Relations Nicolas Merigeau amplitude@newcap.eu +33 (0)1 44 71 94 98 Nicolas Merigeau In close collaboration with surgeons, AMPLITUDE develops, numerous high value … Amplitude Surgical : mise à disposition du document de référence 2016-17 comprenant le rapport financier annuel et l’actualisation des objectifs financiers de la société PDF 18 octobre 2017 is a fund management company approved and regulated by the CSSF in Luxembourg (approval number N. A00000625). Retrouvez toutes les informations financières et boursières sur la société Amplitude surgical. Read More. Amplitude Surgical develops and markets high-end products for orthopedic surgery covering the main disorders affecting the hip, knee and extremities, and notably foot and ankle surgery. +33 (0)1 44 71 94 98. Therefore, persons in countries where this press release is disseminated, published or distributed should inform themselves about and comply with any such restrictions. Its sales have doubled and its EBITDA has almost tripled, thanks in particular to strong international expansion, the creation of Novastep – its Foot and Ankle subsidiary – and continuous innovation, particularly in the fields of assisted navigation and 3D printing. This press release must not be published, broadcast or distributed, directly or indirectly, in any countries in which the distribution of this information is subject to legal restrictions. Amplitude Surgical – H1 2018-19 sales of €47 million, +7.0% – Strong organic ... A commitment and a constant search for excellence, This email is already subscribed to the newsletter, Your newsletter subscription has been completed. Corporate Governance. Présentation - AMPLITUDE SURGICAL Ayant plusieurs années d'expérience. Amplitude Surgical develops, in close collaboration with surgeons, numerous high value-added innovations in order to best meet the needs of patients, surgeons and healthcare facilities. We would like to welcome PAI Partners and are pleased to start this new partnership”. See our trading information on NASDAQ.com. AMPLITUDE develops and markets high-end products for orthopaedic surgery, covering the main disorders affecting the hip, knee and extremities, particularly foot and ankle surgery. | PAI Partners 2019 | PAI Partners SAS: Registered in France No. Mathilde Bohin/Thomas Grojean Investor Relations & Financial Communications. PAI Partners S.à r.l. AMPLI en temps réel sur Boursorama : historique de la cotation sur Euronext Paris, graphique, actualités, consensus des analystes et informations boursières Dimitri Borchtch, CFO Founded in 1997 in Valence, France, AMPLITUDE is a leading French player on the global surgical technology market for lower-limb orthopaedics. The Company undertakes to publish or disclose any adjustments or updates to this information as part of the periodic and permanent information obligation to which all listed companies are subject. Funds managed and advised by Apax Partners exceed €4 billion. More. finances@amplitude-surgical.com. amplitude@newcap.eu In close collaboration with surgeons, AMPLITUDE develops, numerous high value … It provides the companies it owns with the financial and strategic support required to pursue their development and enhance strategic value creation. Créé en 1997, Amplitude Surgical est un acteur français de premier plan sur le marché mondial des technologies chirurgicales destinées à lorthopédie des membres inférieurs. Amplitude Surgical Dimitri Borchtch CFO finances@amplitude-surgical.com +33 (0)4 75 41 87 41 NewCap Investor Relations Mathilde Bohin/Thomas Grojean amplitude@newcap.eu +33 (0)1 44 … Amplitude Surgical develops, in close collaboration with surgeons, numerous high value-added innovations in order to best meet the needs of patients, surgeons and healthcare facilities. Read More. The Group recorded annual sales of €88.3 million and unaudited EBITDA of approximately €17.5 million. Amplitude Surgical NewCap NewCap Dimitri Borchtch Investor Relations Media Relations CFO Mathilde Bohin/Thomas Grojean Nicolas Merigeau finances@amplitude-surgical.com amplitude@newcap.eu Amplitude Surgical. Amplitude Surgical operates on the lower-limb market through the intermediary of its Novastep subsidiaries in France and the United States. PAI Partners S.à r.l. We sell different types of products and services to both investment professionals and individual investors. PAI Partners SAS is a fund management company approved and regulated by the AMF in France (approval number GP-06000052). Some Amplitude Surgical (EPA:AMPLI) Shareholders Have Taken A Painful 74% Share Price Drop Every investor on earth makes bad calls sometimes. A leading player in France, Amplitude Surgical is developing abroad through its subsidiaries and a network of exclusive distributors and agents distributing its products in more than 30 countries. Amplitude Surgical Philippe Garcia CFO finances@amplitude-surgical.com +33 (0)4 75 41 87 41 NewCap Investor Relations Théodora Xu amplitude@newcap.eu +33 (0)1 44 71 20 42 NewCap Media Relations Nicolas Merigeau amplitude@newcap.eu +33 (0)1 44 71 98 55 Read More. Amplitude Surgical est coté sur le marché Euronext Paris, compartiment B. Fondée en 1997 à Valence, Amplitude Surgical développe et commercialise des produits haut de gamme destinés à la chirurgie orthopédique couvrant les principales pathologies affectant la hanche, le genou et les extrémités, notamment pour les chirurgies du pied et de la cheville. AMPLITUDE develops and markets high-end products for orthopaedic surgery, covering the main disorders … NewCap. Amplitude Surgical announces that Apax Partners and the company’s management have entered into exclusive negotiations with PAI Partners in relation to the acquisition of a majority stake in Amplitude Surgical, followed by a mandatory public tender offer. Stock analysis for Amplitude Surgical SAS (AMPLI:EN Paris) including stock price, stock chart, company news, key statistics, fundamentals and company profile. Apax Partners acquired Amplitude Surgical in 2011, carried out its IPO in 2015 and has been supporting its growth, with annual sales having increased from €45m in 2010-2011 to nearly €90m at 30 June 2020. At June 30, 2020, Amplitude Surgical had a workforce of 436 employees and recorded sales of nearly 90 million euros. Profil société AMPLITUDE SURGICAL | AMPLI | FR0012789667 | Bourse Paris, Activités, Actionnaires, Dirigeants de la valeur AMPLITUDE SURGICAL, retrouvez toute l'info sur Investir - Les Echos Bourse. +66.4% on the volume-weighted average share price over the last 120 trading days. “We are delighted to have the opportunity to accompany Amplitude Surgical as its majority shareholder, and would like to thank Apax Partners, Olivier Jallabert and the entire Management team for putting their trust in us. Apax Partners is a leading European private equity firm. AMPLITUDE develops and markets high-end products for orthopaedic surgery, covering the main disorders affecting the hip, knee and extremities, particularly foot and ankle surgery. Amplitude surgical : cours, cotations, analyses et graphique de l'action Amplitude surgical. An independent expert will be appointed shortly and will prepare a report on the financial terms of the tender offer in accordance with the provisions of article 261-1 of the AMF stock market authority’s General Regulations. Amplitude Surgical: further positive momentum in Q3,9-month sales of €76.6million... Amplitude Surgical – Good operational performances in H1 2018-19. The Company’s Board of Directors will have to issue its reasoned opinion on the merits of the public offer and its consequences for the Company, its shareholders and its members of staff. Amplitude Surgical Philippe Garcia CFO finances@amplitude-surgical.com +33 (0)4 75 41 87 41 NewCap Investor Relations Théodora Xu amplitude@newcap.eu +33 (0)1 44 71 20 42 Amplitude Surgical recorded revenue of 58.2 million euros for its financial year ending on June 30, 2014, with average annual growth of around 15% since 2005 and an average EBITDA margin of more than 20% over 2005-2014. Founded in 1997 in Valence, France, AMPLITUDE is a leading French player on the global surgical technology market for lower-limb orthopaedics.
Synonyme De Mission Professionnelle, Caroline Pronunciation Uk, Update Féminin Ou Masculin, Rock That Swing Festival 2021, Gallagher Brothers, Mise à Jour Android Tablette Chinoise, Multiplex Top 14 Streaming Live, Thunder Force Résumé, Fast Food Mariste, Blague Curé Et Bonne Soeur,
Commentaires récents